PORTLAND, Ore., Feb. 22, 2021 /PRNewswire/ — Allied Market Research published a report, titled, “Gene Therapy Cell Culture Media Market by Media Type (Serum Containing Media, Serum Free Media, Stem Cell Media, Specialty Media, Chemically Defined Media, Lysogeny Broth, Custom Media, and Others), Viral Vectors Type (Retroviruses, Lentiviruses, Adenoviruses, Adeno Associated Virus, Herpes Simplex Virus, Poxvirus, Vaccinia Virus, and Others), and End User (Biotechnology & Pharmaceutical Industry, Academic Institute, Research Laboratory, and Others): Global Opportunity Analysis and Industry Forecast, 2020–2027.” According to the report, the global gene therapy cell culture media industry generated $122.60 million in 2019, and is projected to reach $278.96 million by 2027, witnessing a CAGR of 10.6% from 2020 to 2027.
Download Sample Report (Detailed COVID-19 Impact) at: https://www.alliedmarketresearch.com/request-sample/9430
Prime determinants of growth
Rise in R&D investments, surge in awareness regarding gene therapy, advancements related to gene therapy, and increase in prevalence of cancer drive the growth of the global gene therapy cell culture media market. However, scarcity of skilled professionals, high costs related to gene therapies, and ethical & scientific concerns regarding culture media hinder the market growth. On the other hand, untapped potential of the emerging countries present new opportunities in the coming years.
Covid-19 Scenario
- There has been increase in demand for media such as improved protein-free media for growth and development of viral vectors during the pandemic.
- The demand of gene and cell therapy for development of Covid-19 vaccine has been increased in clinical trials as many gene therapy companies perceive this as an opportunity to find vaccine.
The chemically defined media segment to continue its leadership status during the forecast period
Based on media type, the chemically defined media segment accounted for the largest market share, contributing to nearly one-fifth of the global gene therapy cell culture media market in 2019, and will continue its leadership status during the forecast period. This is due to repeated purchase of consumables and increased funding for cell-based research. However, the serum containing media segment is projected to portray the fastest CAGR of 12.2% from 2020 to 2027, owing to its crucial role in drug development and rise in prevalence of cancer globally.
The adenoviruses segment to maintain its lead position by 2027
Based on viral vectors type, the adenoviruses segment accounted for the highest share in 2019, contributed to more than one-fifth of the global gene therapy cell culture media market, and is estimated to maintain its lead position by 2027. This is attributed to increase in government support and ethical acceptance of gene therapy for cancer treatment. Moreover, the lentiviruses segment is expected to manifest the largest CAGR of 18.0% during the forecast period. This is due to increase in prevalence of genetic disorders, cancer, and infectious diseases along with rise in number of clinical studies.
For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/9430
North America to maintain its dominance in terms of revenue throughout the forecast period
Based on region, North America contributed to the highest market share in 2019, accounting for nearly half of the global gene therapy cell culture media market, and will maintain its dominance in terms of revenue throughout the forecast period. This is attributed to increase in production capacity for viral gene and virally modified cell therapy products along with presence of majority of key players. However, Asia-Pacific is estimated to register the fastest CAGR of 13.5% from 2020 to 2027, owing to rise in awareness regarding gene therapy for cancer treatment, development of the R&D sector, and surge in research funding.
Leading market players
- Fujifilm Holdings Corporation
- HiMedia Laboratories Pvt. Ltd.
- Lonza Group Ltd.
- Sartorius AG
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Takara Holdings Inc.
- Novartis International AG
- Bio-Techne Corporation
Avenue Basic Plan | Library Access | 1 Year Subscription |
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter
Get more information: https://www.alliedmarketresearch.com/library-access
We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.
Similar Reports:
Gene Therapy Market – Global Opportunity Analysis and Industry Forecast, 2020–2027
Cancer Gene Therapy Market – Global Opportunity Analysis and Industry Forecast, 2019-2027
Cell Culture Market – Global Opportunity Analysis and Industry Forecast, 2019-2027
3D Cell Culture Market – Global Opportunity Analysis and Industry Forecast, 2019–2027
Culture Media Market – Global Opportunity Analysis and Industry Forecast, 2019–2027
Vero Cell Media Market – Global Opportunity Analysis and Industry Forecast, 2019–2027
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
[email protected]
Web: https://www.alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research
SOURCE Allied Market Research
